1. Institute of Biotechnology, Vilnius University, Vilnius, Lithuania
2. Department of Arctic and Marine Biology, Arctic Infection Biology, UIT-The Arctic University of Norway, Tromsø, Norway
3. Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald - Insel Riems, Germany
4. Present address: NMI TT Pharmaservices, c/o CoLaborator, Berlin, Germany.
5. Department of Medical Biology, University of Tromsø, Tromsø, Norway
6. Westfälische Wilhelms-Universität Münster, Münster, Germany
7. Viral evolution, Robert Koch Institute, Berlin, Germany
8. Division 12 ‘Measles, Mumps, Rubella and Viruses Affecting Immunocompromised Patients’, Robert Koch Institute, Berlin, Germany